Blog: The UK's CBD market - challenges and opportunities for insurers

cannabis oil

The Food Standards Agency recently issued a warning to companies involved in the manufacture and sale of cannabidiol products that goods could be taken off the shelves if those in the industry failed to give more information about the safety and contents of their products by the end of March next year. The lack of a clear regulatory framework has been a major concern for insurers providing cover to the increasing number of businesses selling these products according to Sean Burke, life science team leader at CFC Underwriting.

The approval for use by the NHS England of two cannabis-based medicines to treat epilepsy and multiple sclerosis last November was not only welcomed by charities and campaigners who had been fighting

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here